Pharmaceuticals

Global Loratadine Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-18860667 | Published Date: 05-Aug-2021 | No. of pages: 97

Description

Loratadine is an antihistamine that reduces the effects of natural chemical histamine on the body. Histamine can produce symptoms of sneezing, itching, watery eyes and runny nose. Loratadine is used to treat sneezing, runny nose, tears, hives, rashes, itching and other cold or allergy symptoms. Loratadine is also used to treat urticaria and itching in the skin of people with chronic skin reactions.
The Loratadine market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Loratadine market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Loratadine Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Loratadine market are:
Bayer Healthcare Llc
Ranbaxy Labs Ltd
Lohitha Lifesciences (pvt) Ltd
Taro Pharm
Aurobindo Pharma Ltd
Bionpharma Inc
Vasudha Pharm Chem Limited
Wockhardt Bio Ag
Perrigo
Taro
Marksans Pharma
Teva
Pd Partners
Lannett Co Inc

Most important types of Loratadine products covered in this report are:
Loratadine Tablet
Loratadine capsules
Loratadine syrup

Most widely used downstream fields of Loratadine market covered in this report are:
Adult Drug
Pediatric Drug

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.